CN102579677B - 一种治疗脑胶质瘤的中药组合物 - Google Patents
一种治疗脑胶质瘤的中药组合物 Download PDFInfo
- Publication number
- CN102579677B CN102579677B CN2012100992667A CN201210099266A CN102579677B CN 102579677 B CN102579677 B CN 102579677B CN 2012100992667 A CN2012100992667 A CN 2012100992667A CN 201210099266 A CN201210099266 A CN 201210099266A CN 102579677 B CN102579677 B CN 102579677B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- tumor
- decoct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 201000007983 brain glioma Diseases 0.000 title abstract 4
- 239000003814 drug Substances 0.000 claims description 49
- 206010018338 Glioma Diseases 0.000 claims description 29
- 208000032612 Glial tumor Diseases 0.000 claims description 28
- 230000002490 cerebral effect Effects 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 238000011282 treatment Methods 0.000 claims description 17
- 239000012567 medical material Substances 0.000 claims description 16
- 241000628997 Flos Species 0.000 claims description 10
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 9
- 241000208340 Araliaceae Species 0.000 claims description 8
- 241000717739 Boswellia sacra Species 0.000 claims description 8
- 241001057584 Myrrha Species 0.000 claims description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 8
- 241000237636 Pheretima Species 0.000 claims description 8
- 235000008434 ginseng Nutrition 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 206010010904 Convulsion Diseases 0.000 abstract description 5
- 230000036461 convulsion Effects 0.000 abstract description 5
- 238000002560 therapeutic procedure Methods 0.000 abstract description 5
- 206010019233 Headaches Diseases 0.000 abstract description 4
- 208000009205 Tinnitus Diseases 0.000 abstract description 4
- 231100000869 headache Toxicity 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 231100000886 tinnitus Toxicity 0.000 abstract description 4
- 239000004863 Frankincense Substances 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 240000005528 Arctium lappa Species 0.000 abstract description 2
- 235000003130 Arctium lappa Nutrition 0.000 abstract description 2
- 240000007311 Commiphora myrrha Species 0.000 abstract description 2
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract description 2
- 244000018716 Impatiens biflora Species 0.000 abstract description 2
- 235000015912 Impatiens biflora Nutrition 0.000 abstract description 2
- 241000830535 Ligustrum lucidum Species 0.000 abstract description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 2
- 240000007164 Salvia officinalis Species 0.000 abstract description 2
- 206010047700 Vomiting Diseases 0.000 abstract description 2
- 208000020016 psychiatric disease Diseases 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 208000003174 Brain Neoplasms Diseases 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 241000132446 Inula Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 208000034783 hypoesthesia Diseases 0.000 abstract 1
- 238000011127 radiochemotherapy Methods 0.000 abstract 1
- 230000000007 visual effect Effects 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 38
- 241000699670 Mus sp. Species 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 238000001959 radiotherapy Methods 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000003005 anticarcinogenic agent Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000005017 glioblastoma Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000007917 intracranial administration Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241001116272 Balsaminaceae Species 0.000 description 1
- 241001608538 Boswellia Species 0.000 description 1
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 102100021906 Cyclin-O Human genes 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical group ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 101000897441 Homo sapiens Cyclin-O Proteins 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 241000253121 Inula britannica Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000006266 hibernation Effects 0.000 description 1
- 208000029824 high grade glioma Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 201000011614 malignant glioma Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 229910052705 radium Inorganic materials 0.000 description 1
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
分组 | 样本量(只) | 剂量 |
模型对照组 | 12 | 同体积的生理盐水 |
阳性对照组 | 12 | 注射50mg·kg-1·d-1环磷酰胺 |
中药低剂量组 | 12 | 灌胃5ml·kg-1·d-1中药样品 |
中药高剂量组 | 12 | 灌胃10ml·kg-1·d-1中药样品 |
组别 | 瘤重(g) | 抑制率(%) |
模型对照组 | 2.10±1.03 | - |
阳性对照组 | 0.53±0.50¥¥ | 74.8 |
中药低剂量组 | 1.38±0.61¥ | 34.3 |
中药高剂量组 | 1.06±0.66¥¥ | 49.5 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100992667A CN102579677B (zh) | 2012-04-08 | 2012-04-08 | 一种治疗脑胶质瘤的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100992667A CN102579677B (zh) | 2012-04-08 | 2012-04-08 | 一种治疗脑胶质瘤的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102579677A CN102579677A (zh) | 2012-07-18 |
CN102579677B true CN102579677B (zh) | 2013-09-11 |
Family
ID=46469279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100992667A Active CN102579677B (zh) | 2012-04-08 | 2012-04-08 | 一种治疗脑胶质瘤的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102579677B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2545709C1 (ru) * | 2014-03-28 | 2015-04-10 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ коррекции психических расстройств у больных с глиальными опухолями головного мозга различной локализации в раннем послеоперационном периоде |
CN103933402A (zh) * | 2014-05-05 | 2014-07-23 | 袁聿清 | 一种治疗脑瘤的中药制剂及制备方法 |
CN104491060A (zh) * | 2014-12-05 | 2015-04-08 | 泰山医学院 | 预防脑胶质瘤复发的中药 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1121421A (zh) * | 1994-09-12 | 1996-05-01 | 陈洪英 | 天羚康复丸 |
CN1833681A (zh) * | 2006-01-05 | 2006-09-20 | 阎茂海 | 抗癌参威胶囊及其制备工艺 |
CN101530468A (zh) * | 2008-03-14 | 2009-09-16 | 北京汉潮联创中药科技有限公司 | 一种治疗牙龈恶性肿瘤的中药制剂 |
CN101869623A (zh) * | 2010-05-31 | 2010-10-27 | 兰吉如 | 一种治疗毛发上皮瘤的药物及其制备方法 |
CN102240302A (zh) * | 2011-05-19 | 2011-11-16 | 刘金生 | 超基因活肽中药组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100519456B1 (ko) * | 2002-06-25 | 2005-10-07 | 한국 한의학 연구원 | 항암치료 부작용을 억제하는 효능을 가진 한약재 조성물 |
JP2006117588A (ja) * | 2004-10-22 | 2006-05-11 | Shinhan Sha | 生薬組成物 |
-
2012
- 2012-04-08 CN CN2012100992667A patent/CN102579677B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1121421A (zh) * | 1994-09-12 | 1996-05-01 | 陈洪英 | 天羚康复丸 |
CN1833681A (zh) * | 2006-01-05 | 2006-09-20 | 阎茂海 | 抗癌参威胶囊及其制备工艺 |
CN101530468A (zh) * | 2008-03-14 | 2009-09-16 | 北京汉潮联创中药科技有限公司 | 一种治疗牙龈恶性肿瘤的中药制剂 |
CN101869623A (zh) * | 2010-05-31 | 2010-10-27 | 兰吉如 | 一种治疗毛发上皮瘤的药物及其制备方法 |
CN102240302A (zh) * | 2011-05-19 | 2011-11-16 | 刘金生 | 超基因活肽中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN102579677A (zh) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN103301400A (zh) | 一种治疗慢性萎缩性胃炎的中药组合物及制备方法 | |
CN102198243B (zh) | 一种化瘀温经疏通输卵管的药物 | |
CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN102579677B (zh) | 一种治疗脑胶质瘤的中药组合物 | |
CN101537159B (zh) | 一种中药组合物及其制备方法和应用 | |
CN103211962B (zh) | 一种治疗失眠症的中药组合物 | |
CN103933450A (zh) | 一种预防或/和治疗胃肠疾病的中药组合物及其制备方法 | |
CN102600351B (zh) | 一种治疗皮肤瘙痒症的中药 | |
CN102293941B (zh) | 一种治疗糖尿病的中药组合物 | |
CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
CN101129584A (zh) | 治疗产后缺乳的一种中药制剂 | |
CN104622995A (zh) | 一种治疗慢性浅表性胃炎的药物组合物及其制备方法 | |
CN102488804A (zh) | 一种治疗肝硬化的中药 | |
CN104383270A (zh) | 一种用于冠心病的药物 | |
CN105663838A (zh) | 一种联合硬膜外麻醉治疗胆总管结石的中药及制备方法 | |
CN104666468A (zh) | 一种治疗甲亢、***核的药物组合物 | |
CN105106417A (zh) | 用于治疗老年性皮肤瘙痒症的药物 | |
CN104173952A (zh) | 一种治疗卵巢良性肿瘤的中药组合物 | |
CN104587297A (zh) | 一种治疗硬皮症的中药胶囊及其制备方法 | |
CN104587256A (zh) | 一种治疗***炎的中药组合物 | |
CN104688855A (zh) | 一种治疗慢性疲劳综合症的黄连阿胶组合物及其应用 | |
CN104645233A (zh) | 一种治疗乳腺增生的中药制剂 | |
CN104491690A (zh) | 一种治疗皮肤瘙痒的药物组合物 | |
CN104225506A (zh) | 用于治疗化疗后血小板减少的药物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LI WEILI Free format text: FORMER OWNER: XU CONGYU Effective date: 20130325 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 276017 LINYI, SHANDONG PROVINCE TO: 266200 QINGDAO, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130325 Address after: Jimo City, Shandong province 266200 Jhengtong street Qingdao City No. 20 Applicant after: Li Weili Address before: 276017 A302 building, Linyi hi tech Industrial Development Zone, Shandong, China Applicant before: Xu Congyu |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: QIDONG SANJIANG CONSTRUCTION MACHINERY CO., LTD. Free format text: FORMER OWNER: LI WEILI Effective date: 20140728 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266200 QINGDAO, SHANDONG PROVINCE TO: 226200 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140728 Address after: 226200 Nanhai Road, Binhai Industrial Park, Nantong, Jiangsu, Qidong Patentee after: Qidong Sanjiang Construction Machinery Co., Ltd. Address before: Jimo City, Shandong province 266200 Jhengtong street Qingdao City No. 20 Patentee before: Li Weili |